Evidence review · genuinely contested
Does the Carnivore Diet Raise Your Cholesterol and Heart Disease Risk?
Short answer: LDL cholesterol rising, often substantially, is close to a given on carnivore for most people — that part isn't seriously disputed. Whether that specific rise raises actual heart disease risk is genuinely contested — including among the researchers studying it, one of whom recently had a related finding retracted. This is a "know the settled part, respect the unsettled part, and don't skip the doctor" question, not a yes/no one.
This page is informational, not medical advice — if you're considering carnivore or already on it, get a baseline lipid panel and talk to your doctor, especially with any personal or family history of heart disease.
What the evidence says
Start with what's genuinely settled: for most people, LDL cholesterol rises on carnivore, often into ranges a standard lab would flag as high, sometimes climbing to two or three times pre-diet levels. This is consistent enough across case reports and the people tracking their own bloodwork that it isn't seriously in dispute. Mechanistically it tracks with well-understood lipid biology — a diet very high in saturated fat with essentially zero fiber reliably moves LDL upward in most people who try it.
What's genuinely contested is what that rise means for actual heart disease risk — and this is where it gets interesting rather than simple. A subset of lean, metabolically healthy people on very low-carb diets develop a specific, unusual lipid pattern: high LDL, high HDL, and low triglycerides, all at once. Researchers named this the "lean mass hyper-responder" (LMHR) phenotype after a 2022 peer-reviewed case report first described it, and the pattern-holders' argument is that this combination might not carry the same risk as high LDL usually does, since it appears alongside otherwise healthy metabolic markers.
That argument got a real, dedicated test: a coronary-imaging trial (Budoff and colleagues, published in JACC: Advances, tracking around 100 LMHR or near-LMHR individuals via CT angiography over one year) — built specifically to test whether the phenotype is protected from plaque buildup despite the high LDL. The result wasn't the reassuring one the LMHR hypothesis hoped for: the group showed a meaningful increase in coronary plaque volume over the year, higher than comparable cohorts in other imaging studies. That's a real mark against calling this lipid pattern simply "safe high cholesterol." At the same time, a related follow-up analysis from the same research effort — arguing the progression wasn't actually driven by LDL or ApoB levels — was subsequently retracted. That retraction doesn't undo the main trial's plaque finding, but it's an honest signal this specific sub-question is still being actively fought over in real time, not settled either direction.
So: LDL going up is not in question. Whether the specific "lean and otherwise healthy" pattern protects against that LDL rise's usual consequences is a live, unresolved research fight — not a myth that's already been busted one way or the other, no matter how confidently either side states it online.
Where the experts genuinely disagree
- "High LDL is high LDL, full stop" — the conventional cardiology position: elevated LDL is a well-established, causal risk factor for atherosclerosis regardless of other markers, and the imaging trial's plaque finding reads as confirmation, not surprise.
- "The LMHR pattern might be a genuine exception" — the position behind the original case reports: this combination (high LDL, high HDL, low triglycerides, lean, metabolically healthy) differs enough from typical high-LDL presentations that population-level risk data might not directly apply — a position weakened, but not eliminated, by the plaque-progression finding.
- "We don't have long-term outcome data either way" — arguably the most honest position available: imaging trials measure plaque, not heart attacks or death, and nobody has run this out for the decades it would take to settle the real outcome question.
What to actually do with this
If you're on carnivore or considering it: get a full lipid panel before you start (total cholesterol, LDL, HDL, triglycerides, and ideally ApoB or LDL particle count), retest around 6–8 weeks in, and keep retesting periodically rather than checking once and assuming the number holds. Bring the results to a doctor who'll weigh the whole picture — family history, other risk markers, how you feel — not just one number. Get the data, then get a professional opinion on it.
FAQ
Does everyone's LDL go up on carnivore? Not universally, but it's common enough that assuming it won't happen to you isn't a reasonable bet — check your own numbers rather than go by anecdotes either way.
Does high LDL definitely mean high heart disease risk on this diet? Unresolved — that's the contested part above. Conventional risk models say yes; the LMHR research community argues this pattern might be an exception; the imaging data so far is a mixed signal, not a clean verdict either way.
Should I just avoid carnivore because of this? This page isn't the place for that call — it depends on your baseline risk, family history, and what your own bloodwork shows, which is exactly why the doctor step above isn't optional.
What should I actually ask my doctor for? A full lipid panel including ApoB or LDL particle number if available, not just total cholesterol and LDL — the more detailed markers give a fuller picture than the basic panel most standard checkups default to.
Related reads: Carnivore Diet Side Effects in the First Week: What Actually Happens · Can You Build Muscle While Intermittent Fasting?
This is exactly the kind of question worth bringing to people who've actually gotten their own bloodwork done on this diet, not just a comment section — the tribe's forming at imbatribe.com.
Staying healthy is easier together.
imbatribe is where health tribes meet — get on the waitlist.
Join the waitlist